Herbalife (NYSE:HLF) Price Target Raised to $9.00

Herbalife (NYSE:HLF) had its price objective hoisted by Mizuho from $8.00 to $9.00 in a research report report published on Monday,Benzinga reports. They currently have a neutral rating on the stock.

Several other brokerages have also weighed in on HLF. Citigroup dropped their price objective on shares of Herbalife from $13.00 to $11.00 and set a “buy” rating on the stock in a report on Thursday, May 1st. Wall Street Zen upgraded shares of Herbalife from a “hold” rating to a “buy” rating in a report on Friday, May 30th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Herbalife presently has a consensus rating of “Moderate Buy” and a consensus target price of $11.50.

Herbalife Stock Down 3.0%

HLF stock opened at $9.16 on Monday. The firm has a market cap of $932.95 million, a price-to-earnings ratio of 3.34, a PEG ratio of 0.28 and a beta of 0.89. Herbalife has a 12-month low of $5.04 and a 12-month high of $12.79. The company’s fifty day simple moving average is $8.68 and its 200 day simple moving average is $7.65.

Herbalife (NYSE:HLF) last announced its quarterly earnings data on Wednesday, April 30th. The company reported $0.59 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.19. Herbalife had a net margin of 5.66% and a negative return on equity of 23.75%. The firm had revenue of $1.22 billion for the quarter, compared to analyst estimates of $1.23 billion. During the same quarter in the prior year, the business earned $0.49 earnings per share. The business’s quarterly revenue was down 3.4% compared to the same quarter last year. Research analysts expect that Herbalife will post 1.57 earnings per share for the current year.

Insider Activity at Herbalife

In other Herbalife news, Director Juan Miguel Mendoza bought 5,000 shares of the firm’s stock in a transaction dated Thursday, May 22nd. The stock was bought at an average cost of $6.75 per share, with a total value of $33,750.00. Following the completion of the transaction, the director directly owned 166,857 shares in the company, valued at approximately $1,126,284.75. The trade was a 3.09% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders have bought 13,143 shares of company stock worth $90,973 over the last ninety days. Insiders own 1.73% of the company’s stock.

Institutional Investors Weigh In On Herbalife

Several hedge funds and other institutional investors have recently made changes to their positions in the business. FNY Investment Advisers LLC bought a new stake in shares of Herbalife during the second quarter worth about $29,000. Tweedy Browne Co LLC bought a new stake in shares of Herbalife during the second quarter worth about $186,000. CWM LLC increased its position in shares of Herbalife by 110.0% during the second quarter. CWM LLC now owns 16,734 shares of the company’s stock worth $144,000 after acquiring an additional 8,765 shares in the last quarter. Vanguard Personalized Indexing Management LLC bought a new stake in shares of Herbalife during the second quarter worth about $103,000. Finally, Inspire Investing LLC increased its position in shares of Herbalife by 15.1% during the second quarter. Inspire Investing LLC now owns 45,238 shares of the company’s stock worth $390,000 after acquiring an additional 5,939 shares in the last quarter.

Herbalife Company Profile

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.